Neuroendocrine Causes of Amenorrhea—An Update
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Context: Secondary amenorrhea—the absence of menses for three consecutive cycles—affects approximately 3–4% of reproductive age women, and infertility—the failure to conceive after 12 months of regular intercourse—affects approximately 6–10%. Neuroendocrine causes of amenorrhea and infertility, including functional hypothalamic amenorrhea and hyperprolactinemia, constitute a majority of these cases. Objective: In this review, we discuss the physiologic, pathologic, and iatrogenic causes of amenorrhea and infertility arising from perturbations in the hypothalamic-pituitary-adrenal axis, including potential genetic causes. We focus extensively on the hormonal mechanisms involved in disrupting the hypothalamic-pituitary-ovarian axis. Conclusions: A thorough understanding of the neuroendocrine causes of amenorrhea and infertility is critical for properly assessing patients presenting with these complaints. Prompt evaluation and treatment are essential to prevent loss of bone mass due to hypoestrogenemia and/or to achieve the time-sensitive treatment goal of conception.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
Clément, K., Vaisse, C., Lahlou, N., Cabrol, S., Pelloux, V., Cassuto, D., Gourmelen, M., Dina, C., Chambaz, J., Lacorte, J.-M., et al. (1998) · Nature · doi:10.1038/32911 · Cited by 2,346
Role of Brain Insulin Receptor in Control of Body Weight and Reproduction
Brüning, J. C., Gautam, D., Burks, D. J., Gillette, J., Schubert, M., Orban, P. C., Klein, R., Krone, W., Müller-Wieland, D., & Kahn, C. R. (2000) · Science · doi:10.1126/science.289.5487.2122 · Cited by 2,235
Inagaki, T., Dutchak, P., Zhao, G., Ding, X., Gautron, L., Parameswara, V., Li, Y., Goetz, R., Mohammadi, M., Esser, V., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.003 · Cited by 1,504
Badman, M. K., Pissios, P., Kennedy, A. R., Koukos, G., Flier, J. S., & Maratos-Flier, E. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.002 · Cited by 1,495 · cited 1×
“FGF-21 is a liverderived hormone whose production is up-regulated in response to starvation (15, 16).”
BackgroundA leptin missense mutation associated with hypogonadism and morbid obesity
Strobel, A., Issad, T., Camoin, L., Ozata, M., & Strosberg, A. D. (1998) · Nature Genetics · doi:10.1038/ng0398-213 · Cited by 1,158 · cited 1×
“Mutations of the gene encoding leptin (80), its receptor (81), and mutations in the prohormone convertase 1 gene (82) have all 818 Fourman and Fazeli Neuroendocrine Amenorrhea J Clin Endocrinol Metab, March 2015, 100(3):812–824”
BackgroundJackson, R. S., Creemers, J. W. M., Ohagi, S., Raffin-Sanson, M.-L., Sanders, L., Montague, C. T., Hutton, J. C., & O'Rahilly, S. (1997) · Nature Genetics · doi:10.1038/ng0797-303 · Cited by 1,153
Androgen Excess in Women: Experience with Over 1000 Consecutive Patients
Azziz, R., Sanchez, L. A., Knochenhauer, E. S., Moran, C., Lazenby, J., Stephens, K. C., Taylor, K., & Boots, L. R. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031122 · Cited by 1,132
Recombinant human leptin in women with hypothalamic amenorrhea
Welt, C. K., Chan, J. L., Bullen, J., Murphy, R., Smith, P., DePaoli, A. M., Karalis, A., & Mantzoros, C. S. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040388 · Cited by 908
Franco, B., Guioli, S., Pragliola, A., Incerti, B., Bardoni, B., Tonlorenzi, R., Carrozzo, R., Maestrini, E., Pieretti, M., Taillon-Miller, P., et al. (1991) · Nature · doi:10.1038/353529a0 · Cited by 846 · cited 1×
“These include mutations in the KAL1 gene (74), the FGF-1 receptor (75), FGF-8 (76), the gene encoding semaphorin-3A (77), the CHD7 gene (78), and the genes encoding prokineticin-2 and prokineticin receptor-2 (79).”
BackgroundGenotyping steroid 21-hydroxylase deficiency: hormonal reference data
NEW, M. I., LORENZEN, F., LERNER, A. J., KOHN, B., OBERFIELD, S. E., POLLACK, M. S., DUPONT, B., STONER, E., LEVY, D. J., PANG, S., et al. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-320 · Cited by 624 · cited 2×
“Not detected on newborn screening tests, the most definitive hormonally based diagnostic test for NC21OHD is an ACTH stimulation test measuring serum concentrations of 17hydroxyprogesterone, a substrate of 21-OH, after ACTH administration (108).”
BackgroundHypothalamic-pituitary dysfunction after radiation for brain tumors
Constine, L. S., Woolf, P. D., Cann, D., Mick, G., McCormick, K., Raubertas, R. F., & Rubin, P. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301143280203 · Cited by 619
High frequency of nonclassical steroid 21-hydroxylase deficiency
SPEISER, P. W., DUPONT, B. O., RUBINSTEIN, P., PIAZZA, A., KASTELAN, A., & NEW, M. I. (1986) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198604000-00017 · Cited by 523
de Roux, N., Young, J., Misrahi, M., Genet, R., Chanson, P., Schaison, G., & Milgrom, E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711273372205 · Cited by 518
Endocrine consequences of long-term intrathecal administration of opioids
Abs, R., Verhelst, J., Maeyaert, J., Van Buyten, J.-P., Opsomer, F., Adriaensen, H., Verlooy, J., Van Havenbergh, T., Smet, M., & Van Acker, K. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.6.6615 · Cited by 491
Kallmann Syndrome: Mutations in the Genes Encoding Prokineticin-2 and Prokineticin Receptor-2
Dodé, C., Teixeira, L., Levilliers, J., Fouveaut, C., Bouchard, P., Kottler, M.-L., Lespinasse, J., Lienhardt-Roussie, A., Mathieu, M., Moerman, A., et al. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020175 · Cited by 457
Hypopituitarism Secondary to Head Trauma
Benvenga, S. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.4.1353 · Cited by 423
Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice
Falardeau, J., Chung, W. C. J., Beenken, A., Raivio, T., Plummer, L., Sidis, Y., Jacobson-Dickman, E. E., Eliseenkova, A. V., Ma, J., Dwyer, A., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34538 · Cited by 397 · cited 1×
“These include mutations in the KAL1 gene (74), the FGF-1 receptor (75), FGF-8 (76), the gene encoding semaphorin-3A (77), the CHD7 gene (78), and the genes encoding prokineticin-2 and prokineticin receptor-2 (79).”
BackgroundHormonal and metabolic responses to an enkephalin analogue in normal man
Stubbs, W. A., Jones, A., Edwards, C. R. W., Delitala, G., Jeffcoate, W. J., Ratter, S. J., Besser, G. M., Bloom, S. R., & Alberti, K. G. M. M. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92100-1 · Cited by 353 · cited 1×
“In vitro and human studies suggest that opioids act by directly inhibiting GnRH release (111, 112), although they may also act by inducing hyperprolactinemia (113).”
BackgroundNonclassical 21-Hydroxylase Deficiency
New, M. I. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1645 · Cited by 315
ZACHMANN, M., TASSINARI, D., & PRADER, A. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-56-2-222 · Cited by 293
A genetic basis for functional hypothalamic amenorrhea
Caronia, L. M., Martin, C., Welt, C. K., Sykiotis, G. P., Quinton, R., Thambundit, A., Avbelj, M., Dhruvakumar, S., Plummer, L., Hughes, V. A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa0911064 · Cited by 256 · cited 2×
“Therefore, FHA may stem from interplay between environmental and genetic factors, whereby inherited defects in GnRH biology may lower the threshold at which external stressors suppress the HPO axis (85).”
BackgroundFunctional Hypothalamic Amenorrhea
Gordon, C. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmcp0912024 · Cited by 253
PANG, S., LERNER, A. J., STONER, E., LEVINE, L. S., OBERFIELD, S. E., ENGEL, I., & NEW, M. I. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-3-428 · Cited by 238
FGF21 contributes to neuroendocrine control of female reproduction
Owen, B. M., Bookout, A. L., Ding, X., Lin, V. Y., Atkin, S. D., Gautron, L., Kliewer, S. A., & Mangelsdorf, D. J. (2013) · Nature Medicine · doi:10.1038/nm.3250 · Cited by 230
Dubey, A. K., & Plant, T. M. (1985) · Biology of Reproduction · doi:10.1095/biolreprod33.2.423 · Cited by 217
Late-onset adrenal hyperplasia in hirsutism
Kuttenn, F., Couillin, P., Girard, F., Billaud, L., Vincens, M., Boucekkine, C., Thalabard, J.-C., Maudelonde, T., Spritzer, P., Mowszowicz, I., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198507253130404 · Cited by 213
Hyperprolactinemia-induced ovarian acyclicity is reversed by kisspeptin administration
Sonigo, C., Bouilly, J., Carré, N., Tolle, V., Caraty, A., Tello, J., Simony-Conesa, F.-J., Millar, R., Young, J., & Binart, N. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63937 · Cited by 197 · cited 1×
“In rodent models, prolactin-receptor mRNA has been localized to kisspeptin neurons in the hypothalamus (20), and kisspeptin administration to hyperprolactinemic female mice increases circulating gonadotropin levels and restores ovulation (21).”
BackgroundPubertal Presentation of Congenital Δ5–-3β–Hydroxysteroid Dehydrogenase Deficiency*
ROSENFIELD, R. L., RICH, B. H., WOLFSDORF, J. I., CASSORLA, F., PARKS, J. S., BONGIOVANNI, A. M., WU, C. H., & SHACKLETON, C. H. L. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-51-2-345 · Cited by 135
Kokay, I. C., Petersen, S. L., & Grattan, D. R. (2011) · Endocrinology · doi:10.1210/en.2010-0668 · Cited by 131 · cited 1×
“In rodent models, prolactin-receptor mRNA has been localized to kisspeptin neurons in the hypothalamus (20), and kisspeptin administration to hyperprolactinemic female mice increases circulating gonadotropin levels and restores ovulation (21).”
BackgroundCorticotropin-Releasing Hormone Inhibition of Gonadotropin Release and the Effect of Opioid Blockade
BARBARINO, A., MARINIS, L. D., TOFANI, A., CASA, S. D., D’AMICO, C., MANCINI, A., CORSELLO, S. M., SCIUTO, R., & BARINI, A. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-68-3-523 · Cited by 122 · cited 1×
“In normally cycling women, an infusion of CRH markedly decreases FSH/LH secretion, but GnRH administration prevents this decrease, suggesting that CRH acts by inhibiting GnRH secretion (2).”
BackgroundOral opioids for chronic non-cancer pain: higher prevalence of hypogonadism in men than in women
Fraser, L.-A., Morrison, D., Morley-Forster, P., Paul, T., Tokmakejian, S., Larry Nicholson, R., Bureau, Y., Friedman, T., & Uum, S. H. M. V. (2008) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2008-1076715 · Cited by 112 · cited 1×
“The effect of opioids on the gonadal axis has been extensively studied in men, and hypogonadotropic hypogonadism may be a more common side effect in men compared to women (110).”
BackgroundCHETKOWSKI, R. J., DEFAZIO, J., SHAMONKI, I., JUDD, H. L., & CHANG, R. J. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-58-4-595 · Cited by 108
BOCCUZZI, G., ANGELI, A., BISBOCCI, D., FONZO, D., GAIDANO, G. P., & CERESA, F. (1975) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-40-5-892 · Cited by 96
Matsuzaki, T., Azuma, K., Irahara, M., Yasui, T., & Aono, T. (1994) · Fertility and Sterility · doi:10.1016/s0015-0282(16)57176-3 · Cited by 66 · cited 2×
“This is supported by the fact that in hyperprolactinemic, amenorrheic women, treatment with pulsatile GnRH results in follicular maturation and ovulation when coupled with a human chorionic gonadotropin trigger (18).”
BackgroundOpiates, prolactin, and the dopamine receptor
TOLIS, G., DENT, R., & GUYDA, H. (1978) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-47-1-200 · Cited by 55
Primary Hypothyroidism and Pituitary Enlargement: Radiological Evidence of Pituitary Regression
Jawadi, M. H. (1978) · Archives of Internal Medicine · doi:10.1001/archinte.1978.03630350079021 · Cited by 2
Cited by
Control of puberty onset and fertility by gonadotropin-releasing hormone neurons
Herbison, A. E. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.70 · Cited by 515
The Gonadotropin-Releasing Hormone Pulse Generator
Herbison, A. E. (2018) · Endocrinology · doi:10.1210/en.2018-00653 · Cited by 261
Society for Endocrinology guidelines for testosterone replacement therapy in male hypogonadism
Jayasena, C. N., Anderson, R. A., Llahana, S., Barth, J. H., MacKenzie, F., Wilkes, S., Smith, N., Sooriakumaran, P., Minhas, S., Wu, F. C. W., et al. (2022) · Clinical Endocrinology · doi:10.1111/cen.14633 · Cited by 147
Acute Psychosocial Stress Inhibits LH Pulsatility and Kiss1 Neuronal Activation in Female Mice
Yang, J. A., Song, C. I., Hughes, J. K., Kreisman, M. J., Parra, R. A., Haisenleder, D. J., Kauffman, A. S., & Breen, K. M. (2017) · Endocrinology · doi:10.1210/en.2017-00301 · Cited by 92
Allaway, H. C. M., Southmayd, E. A., & De Souza, M. J. (2016) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2015-0053 · Cited by 89
Metadata
- Authors
- Fourman, L. T., & Fazeli, P. K.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2015-03-01
- Volume
- 100
- Issue
- 3
- Pages
- 812-824
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2101685847
- Cited by
- 145
- References
- 36
- FWCI
- 12.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.